# About Page Founder Profile - Change Verification Checklist

## ‚úÖ All 7 Requested Changes Completed

---

## üìã Change-by-Change Verification

### ‚úÖ Change #1: Title Updated
**Request:** "Title should be: Founder, CEO and Chief AI Strategist"

**Location:** `about.html` line 226, `js/expert-modal.js` line 8

**Status:** ‚úÖ **COMPLETE**

**Verification:**
- [ ] Open `about.html` in browser
- [ ] Scroll to "Our Founder" section
- [ ] Confirm title displays: "Founder, CEO and Chief AI Strategist"
- [ ] Click profile card to open modal
- [ ] Confirm modal header shows same title

---

### ‚úÖ Change #2: Removed Clinical Trial Reference
**Request:** "Remove two AAV programs in clinical trials"

**Location:** `about.html` line 228

**BEFORE:**
```
Led programs at clinical-stage biotechs with two AAV programs in clinical trials.
```

**AFTER:**
```
Successfully led teams and projects at clinical-stage biotechs.
```

**Status:** ‚úÖ **COMPLETE**

**Verification:**
- [ ] Check founder card bio
- [ ] Confirm "two AAV programs in clinical trials" is removed
- [ ] Confirm "Successfully led teams and projects" is present

---

### ‚úÖ Change #3: Vector Expertise Enhanced
**Request:** "Go to Viral Vector Expertise: In the 3rd point: Expert in vector design, capsid selection, and lead candidate selection, preclinical development, scalable vector production, process and analytical development."

**Location:** `js/expert-modal.js` line 24

**BEFORE:**
```
Expert in vector design, capsid selection, and large-scale viral vector production
```

**AFTER:**
```
Expert in vector design, capsid selection, and lead candidate selection, preclinical development, 
scalable vector production, process and analytical development
```

**Status:** ‚úÖ **COMPLETE**

**Verification:**
- [ ] Click on founder profile card to open modal
- [ ] Scroll to "Viral Vector Expertise" section
- [ ] Find the 3rd bullet point
- [ ] Confirm all new elements are present:
  - Lead candidate selection
  - Preclinical development
  - Process and analytical development

---

### ‚úÖ Change #4: Team Leadership Added
**Request:** "Add successfully lead teams and projects"

**Location:** `about.html` line 228, `js/expert-modal.js` line 32

**Status:** ‚úÖ **COMPLETE**

**Implementation:**
- Added to founder card: "Successfully led teams and projects"
- Added to modal Clinical Translation: "Successfully led teams and projects"

**Verification:**
- [ ] Check founder card bio for phrase
- [ ] Open modal and check Clinical Translation section
- [ ] Confirm phrase appears in VeonGen Therapeutics description

---

### ‚úÖ Change #5: Clinical Translation Description Updated
**Request:** "Go to Clinical Translational Experience: Remove Instrumental. Add Worked in three organization"

**Location:** `js/expert-modal.js` line 30

**BEFORE:**
```
Instrumental in three organizations dedicated to bringing transformative therapies to patients
```

**AFTER:**
```
Worked in three organizations dedicated to bringing transformative therapies to patients
```

**Status:** ‚úÖ **COMPLETE**

**Verification:**
- [ ] Open founder modal
- [ ] Find "Clinical Translation Experience" section
- [ ] Confirm description starts with "Worked in three organizations"
- [ ] Confirm "Instrumental" is removed

---

### ‚úÖ Change #6: Company Names Added
**Request:** "Then go to Clinical-Stage Biotech and add the name of the organizations: VeonGen Therapeutics GmBH: A clinical-Stage Biotech (Munich): Evox Therapeutics, and CSL Behring"

**Location:** `js/expert-modal.js` lines 32-34

**BEFORE:**
```
‚Ä¢ Clinical-Stage Biotech (Munich): Two AAV programs successfully advanced to clinical trials
‚Ä¢ Innovative CNS Biotech (Oxford): Pioneering exosome-based approaches...
‚Ä¢ Global Biotech: Ex-vivo gene therapy development...
```

**AFTER:**
```
‚Ä¢ VeonGen Therapeutics GmbH: A Clinical-Stage Biotech (Munich): Successfully led teams and projects
‚Ä¢ Evox Therapeutics: Pioneering exosome-based approaches for CNS disease targeting
‚Ä¢ CSL Behring: Ex-vivo gene therapy development and manufacturing
```

**Status:** ‚úÖ **COMPLETE**

**Verification:**
- [ ] Open founder modal
- [ ] Scroll to "Clinical Translation Experience"
- [ ] Confirm 1st organization: "VeonGen Therapeutics GmbH: A Clinical-Stage Biotech (Munich)"
- [ ] Confirm 2nd organization: "Evox Therapeutics"
- [ ] Confirm 3rd organization: "CSL Behring"
- [ ] Confirm all three companies are explicitly named

---

### ‚úÖ Change #7: Building AI-Native Solution Updated
**Request:** "Then Go to Building the AI-native Solution card: change to: I spent the last several years building deep expertise in AAV gene therapy and AI technologies."

**Location:** `js/expert-modal.js` line 47

**BEFORE:**
```
I spent the last several years building deep expertise in AI technologies.
```

**AFTER:**
```
I spent the last several years building deep expertise in AAV gene therapy and AI technologies.
```

**Status:** ‚úÖ **COMPLETE**

**Verification:**
- [ ] Open founder modal
- [ ] Scroll to "Building the AI-Native Solution" section
- [ ] Confirm text includes "AAV gene therapy and AI technologies"

---

### ‚úÖ Change #8 (BONUS): Key Credentials Overhauled
**Request:** "Then go to Key credential part under the GTC approach: replace 'Clinical program experience (2 AAV programs in trials)' with 'Inner working experience at university spin off, startup and a global biotech' Expertise in use of Advanced AI technology and implementation with a focus on operational efficiencies More than 20 peer-reviewed publications in the top journals like, Science, Cell, Nature comm, EMBO"

**Location:** `js/expert-modal.js` lines 52-57

**BEFORE:**
```
‚úì Clinical program experience (2 AAV programs in trials)
‚úì Advanced AI technology training and implementation
‚úì 16 peer-reviewed publications, 1000+ citations
‚úì Published in Science, Cell, EMBO Journal
```

**AFTER:**
```
‚úì Inner working experience at university spin off, startup and a global biotech
‚úì Expertise in use of Advanced AI technology and implementation with a focus on operational efficiencies
‚úì More than 20 peer-reviewed publications in the top journals like, Science, Cell, Nature comm, EMBO
```

**Status:** ‚úÖ **COMPLETE**

**Verification:**
- [ ] Open founder modal
- [ ] Scroll to bottom to "Key Credentials" section
- [ ] Confirm 3rd credential mentions "university spin off, startup and a global biotech"
- [ ] Confirm 4th credential mentions "focus on operational efficiencies"
- [ ] Confirm 5th credential says "More than 20 peer-reviewed publications"
- [ ] Confirm Nature comm (Nature Communications) is listed

---

## üìÇ Files Changed Summary

### Modified Files:
1. ‚úÖ `about.html` - Founder card (lines 226-228)
2. ‚úÖ `js/expert-modal.js` - Complete modal profile data (lines 8, 24, 30-36, 47, 52-57)
3. ‚úÖ `README.md` - Updated with latest changes
4. ‚úÖ `ABOUT_PAGE_FOUNDER_UPDATES.md` - Complete documentation (NEW)
5. ‚úÖ `ABOUT_PAGE_CHANGES_CHECKLIST.md` - This verification checklist (NEW)

---

## üéØ Quick Visual Test

### **Step 1: Check Founder Card**
```
1. Open about.html in browser
2. Scroll to "Our Founder" section
3. Verify title: "Founder, CEO and Chief AI Strategist"
4. Verify bio ends with: "Successfully led teams and projects at clinical-stage biotechs."
```

### **Step 2: Check Modal Profile**
```
1. Click on Dr. Rahul Kaushik's profile card
2. Modal opens with full profile
3. Check header title matches card title
4. Scroll through each section:
   - Viral Vector Expertise (enhanced point 3)
   - Clinical Translation Experience (3 companies named)
   - Building the AI-Native Solution (AAV + AI)
   - Key Credentials (3 new points)
```

### **Step 3: Mobile Testing**
```
1. Open on mobile device or use browser DevTools
2. Repeat steps 1-2 above
3. Verify modal is fully responsive
4. Verify all text is readable on small screens
```

---

## üöÄ Deployment Ready

- ‚úÖ All 7 requested changes completed
- ‚úÖ Bonus: Key credentials section enhanced
- ‚úÖ Consistent across card and modal
- ‚úÖ Professional positioning enhanced
- ‚úÖ Company transparency improved
- ‚úÖ Documentation complete
- ‚úÖ README.md updated

**Status:** üü¢ **READY FOR PRODUCTION DEPLOYMENT**

---

## üìä Before/After Summary

### **Professional Title:**
- ‚ùå Founder & CEO
- ‚úÖ Founder, CEO and Chief AI Strategist

### **Company Transparency:**
- ‚ùå Generic "Clinical-Stage Biotech (Munich)"
- ‚úÖ **VeonGen Therapeutics GmbH** (named)
- ‚úÖ **Evox Therapeutics** (named)
- ‚úÖ **CSL Behring** (named)

### **Expertise Description:**
- ‚ùå "Large-scale viral vector production"
- ‚úÖ "Lead candidate selection, preclinical development, scalable vector production, process and analytical development"

### **Team Leadership:**
- ‚ùå "Led programs at clinical-stage biotechs with two AAV programs in clinical trials"
- ‚úÖ "Successfully led teams and projects at clinical-stage biotechs"

### **Publications:**
- ‚ùå "16 peer-reviewed publications, 1000+ citations"
- ‚úÖ "More than 20 peer-reviewed publications in the top journals like, Science, Cell, Nature comm, EMBO"

### **AI Expertise:**
- ‚ùå "Advanced AI technology training and implementation"
- ‚úÖ "Expertise in use of Advanced AI technology and implementation with a focus on operational efficiencies"

### **Organizational Experience:**
- ‚ùå "Clinical program experience (2 AAV programs in trials)"
- ‚úÖ "Inner working experience at university spin off, startup and a global biotech"

---

## ‚úÖ Final Verification

**Test in Browser:**
1. [ ] Open `about.html`
2. [ ] Verify founder card displays correctly
3. [ ] Click card to open modal
4. [ ] Review all 7 sections for changes
5. [ ] Test on mobile device
6. [ ] Verify all links work
7. [ ] Check for any typos or formatting issues

**All Clear?** ‚Üí Ready to deploy! üöÄ

---

**Date:** 2025-11-21  
**Status:** ‚úÖ **ALL CHANGES COMPLETE**  
**Tested:** Ready for verification  
**Next Step:** Deploy to production
